Patients with diabetic macular edema previously treated with a ranibizumab biosimilar in India experience comparable safety ...

Patients with diabetic macular edema previously treated with a ranibizumab biosimilar in India experience comparable safety and efficacy after being switched to another ranibizumab biosimilar, ...

Biocon’s ustekinumab biosimilar matched reference ustekinumab in efficacy and safety, while an adalimumab biosimilar proved ...

The introduction of biosimilars in the treatment of age-related macular degeneration (AMD) is raising concerns among ...

Global biosimilar regulatory harmonization will be needed to reduce development costs and improve patient access, despite ...

The Banking of Biosimilars: Insights From a Leading Health Economist ...

To read all of these articles and more, visit centerforbiosimilars.com.

Celltrion and Formycon with Fresenius Kabi launched their respective ustekinumab biosimilars (Steqeyma and Otulfi), joining 4 ...